The data from Zhu et al. (2014) have shown that inhibiting CSF-1R signaling depletes CD206hi TAMs and reprograms the remaining macrophages to immune-active M1 type, paralleling with enhanced antitumor interferon, promoting T-cell infiltration, and preventing tumor progression. Here, CSF1R is linked to neoplasm.